Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals?

Table 1 Mean of the proximal femur bone mineral density, predicted 10-year major osteoporotic fracture and hip fracture probability estimated for all patients at baseline, 2-year and 5-year

	At baselinemean ± SD	2-yr of treatmentmean ± SD	5-yr of treatmentmean ± SD
Total proximal femur BMD	0.553 ± 0.69	0.574 ± 0.06	0.579 ± 0.04
T-score	-2.75 ± 0.61	-2.32 ± 0.45	-1.46 ± 0.35
FRAX 10-yr major osteoporosis fracture risk	21.43 ± 7.56	14.81 ± 4.79	9.67 ± 2.92
FRAX 10-yr hip fracture risk	7.11 ± 4.55	4.4 ± 2.62	4.11 ± 4.55

BMD: Bone mineral density; FRAX: The World Health Organization fracture risk assessment tool.